PROGRAMMED CELL DEATH (PD-1) INHIBITOR THERAPY FOR PATIENTS WITH PD-1-EXPRESSING CANCERS

• 收藏
• 分享

专利权人:

发明人:

Tobias SCHATTON,Sonja KLEFFEL,Christian POSCH

申请号：

US15751921

公开号：

US20180231554A1

申请日:

2016.09.02

申请国别(地区):

US

年份:

2018

代理人:

摘要：

Described herein are biomarkers comprising mTOR, PI3K/AKT, and MAPK/ERK signaling pathway members as well as cap-dependent translation initiation factors that enable monitoring and predicting responses to PD-1 pathway blockade in patients afflicted with cancers characterized by PD-1 expression.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/